Table of Content

1 Cancer Drugs Market Overview
1.1 Product Overview and Scope of Cancer Drugs
1.2 Cancer Drugs Segment by Type
1.2.1 Global Cancer Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Drugs Segment by Application
1.3.1 Global Cancer Drugs Market Value by Application: (2024-2034)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Global Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Cancer Drugs Revenue 2018-2029
1.4.2 Global Cancer Drugs Sales 2018-2029
1.4.3 Global Cancer Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cancer Drugs Market Competition by Manufacturers
2.1 Global Cancer Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Cancer Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Cancer Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Cancer Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Cancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Drugs, Product Type & Application
2.7 Cancer Drugs Market Competitive Situation and Trends
2.7.1 Cancer Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cancer Drugs Players Market Share by Revenue
2.7.3 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Drugs Retrospective Market Scenario by Region
3.1 Global Cancer Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cancer Drugs Global Cancer Drugs Sales by Region: 2018-2029
3.2.1 Global Cancer Drugs Sales by Region: 2018-2024
3.2.2 Global Cancer Drugs Sales by Region: 2024-2029
3.3 Global Cancer Drugs Global Cancer Drugs Revenue by Region: 2018-2029
3.3.1 Global Cancer Drugs Revenue by Region: 2018-2024
3.3.2 Global Cancer Drugs Revenue by Region: 2024-2029
3.4 North America Cancer Drugs Market Facts & Figures by Country
3.4.1 North America Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cancer Drugs Sales by Country (2018-2029)
3.4.3 North America Cancer Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Drugs Market Facts & Figures by Country
3.5.1 Europe Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cancer Drugs Sales by Country (2018-2029)
3.5.3 Europe Cancer Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cancer Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Cancer Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cancer Drugs Sales by Country (2018-2029)
3.7.3 Latin America Cancer Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cancer Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cancer Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Drugs Sales by Type (2018-2029)
4.1.1 Global Cancer Drugs Sales by Type (2018-2024)
4.1.2 Global Cancer Drugs Sales by Type (2024-2029)
4.1.3 Global Cancer Drugs Sales Market Share by Type (2018-2029)
4.2 Global Cancer Drugs Revenue by Type (2018-2029)
4.2.1 Global Cancer Drugs Revenue by Type (2018-2024)
4.2.2 Global Cancer Drugs Revenue by Type (2024-2029)
4.2.3 Global Cancer Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Cancer Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cancer Drugs Sales by Application (2018-2029)
5.1.1 Global Cancer Drugs Sales by Application (2018-2024)
5.1.2 Global Cancer Drugs Sales by Application (2024-2029)
5.1.3 Global Cancer Drugs Sales Market Share by Application (2018-2029)
5.2 Global Cancer Drugs Revenue by Application (2018-2029)
5.2.1 Global Cancer Drugs Revenue by Application (2018-2024)
5.2.2 Global Cancer Drugs Revenue by Application (2024-2029)
5.2.3 Global Cancer Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Cancer Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Roche Cancer Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novartis Cancer Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Celgene Cancer Drugs Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Bristol-Myers Squibb Cancer Drugs Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Amgen Cancer Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Johnson & Johnson Cancer Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Cancer Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Corporation Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Takeda Cancer Drugs Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Eli Lilly Cancer Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Corporation Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 AstraZeneca Cancer Drugs Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Astellas
6.11.1 Astellas Corporation Information
6.11.2 Astellas Cancer Drugs Description and Business Overview
6.11.3 Astellas Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Astellas Cancer Drugs Product Portfolio
6.11.5 Astellas Recent Developments/Updates
6.12 Merck & Co.
6.12.1 Merck & Co. Corporation Information
6.12.2 Merck & Co. Cancer Drugs Description and Business Overview
6.12.3 Merck & Co. Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Merck & Co. Cancer Drugs Product Portfolio
6.12.5 Merck & Co. Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Cancer Drugs Description and Business Overview
6.13.3 Sanofi Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Sanofi Cancer Drugs Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Cancer Drugs Description and Business Overview
6.14.3 Bayer Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Bayer Cancer Drugs Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Biogen Idec
6.15.1 Biogen Idec Corporation Information
6.15.2 Biogen Idec Cancer Drugs Description and Business Overview
6.15.3 Biogen Idec Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Biogen Idec Cancer Drugs Product Portfolio
6.15.5 Biogen Idec Recent Developments/Updates
6.16 Eisai
6.16.1 Eisai Corporation Information
6.16.2 Eisai Cancer Drugs Description and Business Overview
6.16.3 Eisai Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Eisai Cancer Drugs Product Portfolio
6.16.5 Eisai Recent Developments/Updates
6.17 Teva
6.17.1 Teva Corporation Information
6.17.2 Teva Cancer Drugs Description and Business Overview
6.17.3 Teva Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Teva Cancer Drugs Product Portfolio
6.17.5 Teva Recent Developments/Updates
6.18 Otsuka
6.18.1 Otsuka Corporation Information
6.18.2 Otsuka Cancer Drugs Description and Business Overview
6.18.3 Otsuka Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Otsuka Cancer Drugs Product Portfolio
6.18.5 Otsuka Recent Developments/Updates
6.19 Merck KGaA
6.19.1 Merck KGaA Corporation Information
6.19.2 Merck KGaA Cancer Drugs Description and Business Overview
6.19.3 Merck KGaA Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Merck KGaA Cancer Drugs Product Portfolio
6.19.5 Merck KGaA Recent Developments/Updates
6.20 Ipsen
6.20.1 Ipsen Corporation Information
6.20.2 Ipsen Cancer Drugs Description and Business Overview
6.20.3 Ipsen Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Ipsen Cancer Drugs Product Portfolio
6.20.5 Ipsen Recent Developments/Updates
6.21 AbbVie
6.21.1 AbbVie Corporation Information
6.21.2 AbbVie Cancer Drugs Description and Business Overview
6.21.3 AbbVie Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.21.4 AbbVie Cancer Drugs Product Portfolio
6.21.5 AbbVie Recent Developments/Updates
6.22 Gilead Sciences
6.22.1 Gilead Sciences Corporation Information
6.22.2 Gilead Sciences Cancer Drugs Description and Business Overview
6.22.3 Gilead Sciences Cancer Drugs Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Gilead Sciences Cancer Drugs Product Portfolio
6.22.5 Gilead Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Drugs Industry Chain Analysis
7.2 Cancer Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Drugs Production Mode & Process
7.4 Cancer Drugs Sales and Marketing
7.4.1 Cancer Drugs Sales Channels
7.4.2 Cancer Drugs Distributors
7.5 Cancer Drugs Customers
8 Cancer Drugs Market Dynamics
8.1 Cancer Drugs Industry Trends
8.2 Cancer Drugs Market Drivers
8.3 Cancer Drugs Market Challenges
8.4 Cancer Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cancer Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Cancer Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Cancer Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cancer Drugs Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Cancer Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Cancer Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Cancer Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Cancer Drugs Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Cancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Cancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 18. Global Cancer Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Cancer Drugs Sales by Region (2024-2029) & (K MT)
Table 20. Global Cancer Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Cancer Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Cancer Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 27. North America Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 28. North America Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 32. Europe Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 33. Europe Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Cancer Drugs Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Cancer Drugs Sales (K MT) by Type (2018-2024)
Table 51. Global Cancer Drugs Sales (K MT) by Type (2024-2029)
Table 52. Global Cancer Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Cancer Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Cancer Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Cancer Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Cancer Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Cancer Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Cancer Drugs Price (USD/MT) by Type (2018-2024)
Table 59. Global Cancer Drugs Price (USD/MT) by Type (2024-2029)
Table 60. Global Cancer Drugs Sales (K MT) by Application (2018-2024)
Table 61. Global Cancer Drugs Sales (K MT) by Application (2024-2029)
Table 62. Global Cancer Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Cancer Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Cancer Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Cancer Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Cancer Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Cancer Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Cancer Drugs Price (USD/MT) by Application (2018-2024)
Table 69. Global Cancer Drugs Price (USD/MT) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Roche Cancer Drugs Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Novartis Cancer Drugs Product
Table 79. Novartis Recent Developments/Updates
Table 80. Celgene Corporation Information
Table 81. Celgene Description and Business Overview
Table 82. Celgene Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Celgene Cancer Drugs Product
Table 84. Celgene Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Bristol-Myers Squibb Cancer Drugs Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Amgen Cancer Drugs Product
Table 94. Amgen Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Johnson & Johnson Cancer Drugs Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Pfizer Cancer Drugs Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Takeda Corporation Information
Table 106. Takeda Description and Business Overview
Table 107. Takeda Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. Takeda Cancer Drugs Product
Table 109. Takeda Recent Developments/Updates
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Eli Lilly Cancer Drugs Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. AstraZeneca Cancer Drugs Product
Table 119. AstraZeneca Recent Developments/Updates
Table 120. Astellas Corporation Information
Table 121. Astellas Description and Business Overview
Table 122. Astellas Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Astellas Cancer Drugs Product
Table 124. Astellas Recent Developments/Updates
Table 125. Merck & Co. Corporation Information
Table 126. Merck & Co. Description and Business Overview
Table 127. Merck & Co. Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Merck & Co. Cancer Drugs Product
Table 129. Merck & Co. Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Sanofi Cancer Drugs Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Bayer Corporation Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Bayer Cancer Drugs Product
Table 139. Bayer Recent Developments/Updates
Table 140. Biogen Idec Corporation Information
Table 141. Biogen Idec Description and Business Overview
Table 142. Biogen Idec Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Biogen Idec Cancer Drugs Product
Table 144. Biogen Idec Recent Developments/Updates
Table 145. Eisai Corporation Information
Table 146. Eisai Description and Business Overview
Table 147. Eisai Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Eisai Cancer Drugs Product
Table 149. Eisai Recent Developments/Updates
Table 150. Teva Corporation Information
Table 151. Teva Description and Business Overview
Table 152. Teva Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Teva Cancer Drugs Product
Table 154. Teva Recent Developments/Updates
Table 155. Otsuka Corporation Information
Table 156. Otsuka Description and Business Overview
Table 157. Otsuka Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. Otsuka Cancer Drugs Product
Table 159. Otsuka Recent Developments/Updates
Table 160. Merck KGaA Corporation Information
Table 161. Merck KGaA Description and Business Overview
Table 162. Merck KGaA Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Merck KGaA Cancer Drugs Product
Table 164. Merck KGaA Recent Developments/Updates
Table 165. Ipsen Corporation Information
Table 166. Ipsen Description and Business Overview
Table 167. Ipsen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. Ipsen Cancer Drugs Product
Table 169. Ipsen Recent Developments/Updates
Table 170. AbbVie Corporation Information
Table 171. AbbVie Description and Business Overview
Table 172. AbbVie Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. AbbVie Cancer Drugs Product
Table 174. AbbVie Recent Developments/Updates
Table 175. Gilead Sciences Corporation Information
Table 176. Gilead Sciences Description and Business Overview
Table 177. Gilead Sciences Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 178. Gilead Sciences Cancer Drugs Product
Table 179. Gilead Sciences Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Cancer Drugs Distributors List
Table 183. Cancer Drugs Customers List
Table 184. Cancer Drugs Market Trends
Table 185. Cancer Drugs Market Drivers
Table 186. Cancer Drugs Market Challenges
Table 187. Cancer Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cancer Drugs
Figure 2. Global Cancer Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Cancer Drugs Market Share by Type in 2022 & 2029
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Cancer Drugs Market Share by Application in 2022 & 2029
Figure 11. Blood Cancer
Figure 12. Breast Cancer
Figure 13. Gastrointestinal Cancer
Figure 14. Prostate Cancer
Figure 15. Respiratory/Lung Cancer
Figure 16. Other Cancers
Figure 17. Global Cancer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Cancer Drugs Market Size (2018-2029) & (US$ Million)
Figure 19. Global Cancer Drugs Sales (2018-2029) & (K MT)
Figure 20. Global Cancer Drugs Average Price (USD/MT) & (2018-2029)
Figure 21. Cancer Drugs Report Years Considered
Figure 22. Cancer Drugs Sales Share by Manufacturers in 2022
Figure 23. Global Cancer Drugs Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Cancer Drugs Players: Market Share by Revenue in 2022
Figure 25. Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 28. North America Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 29. U.S. Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 32. Europe Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 33. Germany Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Cancer Drugs Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Cancer Drugs Revenue Market Share by Region (2018-2029)
Figure 40. China Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Taiwan Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Philippines Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 51. Latin America Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 56. Middle East & Africa Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. U.A.E Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Sales Market Share of Cancer Drugs by Type (2018-2029)
Figure 61. Global Revenue Market Share of Cancer Drugs by Type (2018-2029)
Figure 62. Global Cancer Drugs Price (USD/MT) by Type (2018-2029)
Figure 63. Global Sales Market Share of Cancer Drugs by Application (2018-2029)
Figure 64. Global Revenue Market Share of Cancer Drugs by Application (2018-2029)
Figure 65. Global Cancer Drugs Price (USD/MT) by Application (2018-2029)
Figure 66. Cancer Drugs Value Chain
Figure 67. Cancer Drugs Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed